Adjuvant chemotherapy in breast cancer: back to the future

Onkologie. 2003 Apr;26(2):111-2. doi: 10.1159/000071509.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Dose-Response Relationship, Drug
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use
  • Drug Administration Schedule
  • Female
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use
  • Humans
  • Lymphatic Metastasis
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Neoplasm Staging
  • Randomized Controlled Trials as Topic
  • Vincristine / adverse effects
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF protocol
  • CMFDV protocol